APA

Peloquin C. A., Velásquez G. E., Lecca L., Calderón R. I., Coit J., Milstein M., Osso E., Jimenez J., Tintaya K., Garavito E. S., Vasquez D. V., Mitnick C. D. & Davies G. (092017). Erratum for Peloquin et al., "Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis". : Antimicrobial agents and chemotherapy.

Chicago

Peloquin C A, Velásquez G E, Lecca L, Calderón R I, Coit J, Milstein M, Osso E, Jimenez J, Tintaya K, Garavito E Sanchez, Vasquez D Vargas, Mitnick C D and Davies G. 092017. Erratum for Peloquin et al., "Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis". : Antimicrobial agents and chemotherapy.

Harvard

Peloquin C. A., Velásquez G. E., Lecca L., Calderón R. I., Coit J., Milstein M., Osso E., Jimenez J., Tintaya K., Garavito E. S., Vasquez D. V., Mitnick C. D. and Davies G. (092017). Erratum for Peloquin et al., "Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis". : Antimicrobial agents and chemotherapy.

MLA

Peloquin C A, Velásquez G E, Lecca L, Calderón R I, Coit J, Milstein M, Osso E, Jimenez J, Tintaya K, Garavito E Sanchez, Vasquez D Vargas, Mitnick C D and Davies G. Erratum for Peloquin et al., "Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis". : Antimicrobial agents and chemotherapy. 092017.